CIK 0001339970
- Non-accelerated filer
- Smaller reporting company
aTYR PHARMA INC
Sign in to watch- Ticker
- ATYR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 203435077
- Phone
- +1 858-731-8389
- Business address
- 10240 SORRENTO VALLEY ROAD, SUITE 300, SAN DIEGO, CA, 92121
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-05-08 | BLAIR JAMES C Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2018-05-15 | BLAIR JAMES C Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2017-05-09 | BLAIR JAMES C Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2016-05-24 | BLAIR JAMES C Director | Grant or award · Stock Option (right to buy) | +18,000 | 18,000 | ||
| 2016-01-27 | BLAIR JAMES C Director | Grant or award · Stock Option (right to buy) | +19,428 | 19,428 | ||
| 2015-07-08 | BLAIR JAMES C Director | Grant or award · Stock Option (right to buy) | +6,286 | 6,286 |
Page 1 of 1 · 6 trades